It's 2026!🎉
We will be counting down the Top Ten Nephrology Stories of 2025 on 1/6/26 at 9 pm EST.
Join us on TWITTER (yes, it will always be Twitter to us).
Come on by #NephJC faithful for a lively discussion! You picked & we're count'em down.
https://t.co/no5pfFdPN8
💫 2025 was a landmark year for glomerular diseases!
Major advances for GN treatment, from IgAN and lupus nephritis to rare diseases like C3G.
Can’t wait for what’s coming next!
And the eGFR outcomes!
Hope these new treatment options are soon available in our countries.
#2025 #GlomerularDiseases #IgAN #LN #C3G #GlomLove
Deeply appreciative of @vjha126 's talk at #ISNCON25 asking Nephrologists in India to indulge in some sort of research.
But at the free paper presentation session, a place where folks doing such research are presenting their findings, the audience was thin, almost non-existent!
@SayaliBThakare#ISNCON2025
Most common genotype in 🇮🇳 and Asia- SLC4A1-biallelic type
Rarest one is FOXI1- 4th case ever described till now was found during this study
#ISNCON25-what a ride🚀
From writing newsletters✍️
Presenting poster📊
Chairing sessions🎤
Part of the organising committee & the buzzing social media team📸
To the unforgettable alumni meet💫
So many hats,1 big heart full of gratitude❤️
Thank you @Narayansgpgims@drshyambansal
@SayaliBThakare#ISNCON2025
Bansal Oration of topic- primary distal RTA research done by dr sayali herself at KEM, Mumbai
Prevelance, manifestation- renal, metabolic and extra-renal
👁️ 🩺 Nephrology meets opthalmology💥💥🦋
💬 Question for #NephTwitter:
Which eye finding has helped you diagnose a renal syndrome before labs could?
👁️ Lenticonus?
👁️ Cornea verticillata?
👁️ Coloboma?
👁️ Hamartoma?
✨ Let’s look closer in the eyes, here is a infographic by me👇👇
👁️ + 🧬 + 🩺 = 💙
#RareDisease #Nephrology
👉 Discussed the Nefigard trial and the effect of enteric release Budesonide
👉Points to the differences in different formulations of budesonide compared to Nefecon